TY  JOUR
TI  Secondary amyloidosis as a complication of rheumatoid arthritis in a patient with low adherence to treatment
KW  secondary amyloidosis
KW  rheumatoid arthritis
KW  proteinuria
KW  leflunomide
KW  olokizumab
JO  Clinical Medicine and Pharmacology
AU  Nikulina, D.B.
PY  2023
IS  8
PB  LLC Information and publishing center Innovations and investments